Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LE.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.7.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.49.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.3.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LB.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.3.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GE.1.2.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.58.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.8.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.1.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDD.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDNNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LT.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.8.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LV.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.54.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.30.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.1.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
MN.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.63NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LE.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LH.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HW.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-12971.4China
JN.1.55.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.18.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDK.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LS.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.1 (Omicron)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4 (Omicron)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17507.2China
FL.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HD.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HQ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FD.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GK.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.2.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FK.1.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FT.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GJ.1.2.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.25NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used